() has moved away from bulk metals like iron and coal, securing an option to acquire up to 50% of an Australian firm with nickel and rare earth exploration potential.
John Peters, executive chairman, said: “This opportunity came along in a sector that we believe has good medium and long-term prospects.”
In a separate statement, the group said it had stopped activity on its Tatu coal project in New Zealand to concentrate on this new project.
Meet Allergy Therapeutics plc, Cello Group plc, Sphere Medical Holding PLC and ValiRx Plc at our event,
London, 06 October 2016.
Register here »